Related Experiment Video
Updated: Aug 3, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase
R D DeHaan1, E M Yazlovitskaya, D L Persons
1Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City 66160-7232, USA.
Abstract:
The extracellular signal-regulated kinase (ERK) pathway is among several signal transduction pathways that are activated in response to exposure to the DNA damage-inducing chemotherapeutic agent cisplatin. We have previously reported that inhibition of cisplatin-induced ERK activity enhances sensitivity to cisplatin. Furthermore, we have demonstrated that cisplatin-induced ERK activation is required for optimal p53 protein accumulation following cisplatin-induced DNA damage. In the present study, we expanded our investigations to examine the effect of cisplatin-induced ERK activation on the expression of p53-targeted genes that have been shown to be important in the cellular response to DNA damage including Bax, Bcl-2, Bcl-x1, Cyclin G, Gadd45, p21WAF1, and Mdm2. In the ovarian carcinoma cell line A2780, cisplatin was shown to induce expression of p21WAF1, Gadd45 and Mdm2, but cisplatin had no effect on expression of Bax, Bcl-2, Bcl-x1, or Cyclin G. Inhibition of cisplatin-induced ERK activity by PD98059 resulted in decreased levels of p21WAF1, Gadd45 and Mdm2. These results provide evidence that ERK activity during the cisplatin DNA damage response, regulates in part, these cell cycle control (p21WAF1, Gadd45), DNA repair (Gadd45) and p53-regulatory (Mdm2) proteins.
Insights
The extracellular signal-regulated kinase (ERK) pathway regulates key proteins involved in DNA repair and cell cycle control following cisplatin chemotherapy. Inhibiting ERK activity reduces the expression of these essential proteins, impacting cellular response to DNA damage.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Cisplatin is a DNA damage-inducing chemotherapeutic agent.
- The extracellular signal-regulated kinase (ERK) pathway is activated by cisplatin.
- ERK pathway inhibition enhances cisplatin sensitivity and is required for p53 accumulation.
Purpose of the Study:
- To investigate the effect of cisplatin-induced ERK activation on p53-targeted genes.
- To determine the role of ERK in regulating genes crucial for DNA damage response.
Main Methods:
- Utilized the A2780 ovarian carcinoma cell line.
- Administered cisplatin to induce DNA damage and ERK activation.
- Inhibited ERK activity using PD98059.
- Analyzed the expression of p53-targeted genes (Bax, Bcl-2, Bcl-x1, Cyclin G, Gadd45, p21WAF1, Mdm2) via quantitative analysis.
Main Results:
- Cisplatin upregulated p21WAF1, Gadd45, and Mdm2 expression.
- Cisplatin did not affect the expression of Bax, Bcl-2, Bcl-x1, or Cyclin G.
- Inhibition of ERK activity by PD98059 decreased the levels of p21WAF1, Gadd45, and Mdm2.
Conclusions:
- ERK activity plays a regulatory role in the cisplatin DNA damage response.
- ERK influences the expression of cell cycle control (p21WAF1, Gadd45), DNA repair (Gadd45), and p53-regulatory (Mdm2) proteins.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway

